Просмотр новости
Найдите то, что Вас интересует
Спутники
РН
SpaceX
Роскосмос
NASA
Adhesion Barrier Market by Product [Synthetic (Hyaluronic Acid, Polyethylene Glycol), Natural], Type (Film, Gel, Liquid), Application (Abdominal, Orthopedic, Cardiovascular, Gynecological Surgery), End User (Hospitals & Clinics) - Global Forecast to 2031..., Market Research Report: MarketsandMarkets
Дата публикации: 01-07-2026 00:00:00
Основное содержимое страницы с новостью.
Adhesion Barrier Market by Product [Synthetic (Hyaluronic Acid, Polyethylene Glycol), Natural], Type (Film, Gel, Liquid), Application (Abdominal, Orthopedic, Cardiovascular, Gynecological Surgery), End User (Hospitals & Clinics) - Global Forecast to 2031
USD 1.11 BN
MARKET SIZE, 2031
ADHESION BARRIER MARKET SIZE, SHARE & GROWTH SNAPSHOT
Source: Secondary Research, Interviews with Experts, MarketsandMarkets Analysis
The global adhesion barrier market is projected to grow from USD 0.78 billion in 2026 to USD 1.11 billion by 2031, at a CAGR of 7.3% during the forecast period. The market was valued at USD 0.73 billion in 2025. Advancements in biomaterials, including hyaluronic acid, carboxymethylcellulose, oxidized regenerated cellulose, collagen, and synthetic polymer-based formulations, are supporting the development of safer, absorbable, and easy-to-apply adhesion prevention products. Growing adoption in gynecological, abdominal, orthopedic, cardiovascular, neurological, and urological surgeries, along with increasing surgeon awareness and expanding access to advanced surgical products in emerging markets, is further driving global demand for adhesion barriers.
KEY TAKEAWAYS
-
BY REGION
North America accounted for the largest share, 40-45%, of the global adhesion barrier market in 2025
-
BY PRODUCT
By product, the synthetic adhesion segment is expected to register the highest CAGR of 7.4-7.6% in the market.
-
BY FORMULATION
By formulation, the gel formulation segment is projected to grow at the highest CAGR of 8.0-8.3% from 2026 to 2031.
-
BY APPLICATION
By application, the general/abdominal segment is expected to dominate the market.
-
BY END USER
By end user, the hospitals & clinics segment is expected to dominate the market.
-
Competitive Landscape
Baxter, Johnson & Johnson, and Medtronic were identified as some of the star players in the global adhesion barrier market, given their strong market share and product footprint.
-
Competitive Landscape
Womed (France) and Semical (Turkey) have distinguished themselves among startups and SMEs by securing strong footholds in specialized niche areas, underscoring their potential as emerging market leaders.
The global adhesion barrier market is witnessing steady growth, driven by several key factors. The rising volume of surgical procedures, supported by the growing burden of chronic diseases, aging populations, and increasing prevalence of adhesion-related post-surgical complications, is driving demand for effective adhesion prevention products. In addition, advancements in biomaterials, including hyaluronic acid, carboxymethylcellulose, collagen, oxidized regenerated cellulose, and synthetic polymer-based formulations, along with the growing adoption of absorbable film, gel, liquid, and spray-gel barriers, are improving product safety, ease of application, and clinical effectiveness across a wide range of surgical specialties worldwide.
TRENDS & DISRUPTIONS IMPACTING CUSTOMERS' CUSTOMERS
The adhesion barrier market is shifting from conventional film and sheet-based products toward advanced gel, liquid, spray-gel, and powder-to-gel formulations. Innovations in absorbable biomaterials such as hyaluronic acid, carboxymethylcellulose, collagen, oxidized regenerated cellulose, and synthetic polymers are improving ease of use, tissue coverage, and biocompatibility. These developments are supporting wider adoption across gynecological, abdominal, orthopedic, cardiovascular, neurological, and urological surgeries, as healthcare providers focus on reducing post-surgical adhesions, repeat surgeries, pain, infertility, and bowel obstruction.
Source: Secondary Research, Interviews with Experts, MarketsandMarkets Analysis
MARKET DYNAMICS
-
Reluctance of surgeons to use adhesion barriers
OPPORTUNITIES
Impact
Level
-
Untapped markets in emerging economies
-
Stringent regulations and limited technological innovations
Source: Secondary Research, Interviews with Experts, MarketsandMarkets Analysis
The rapidly growing geriatric population globally is a key driver for the adhesion barrier market, as older adults are more prone to chronic diseases and age-related conditions that often require surgical intervention. According to the WHO, by 2030, 1 in 6 people worldwide will be aged 60 years or over, and by 2050, the population aged 60 years and above is expected to reach 2.1 billion. In addition, the number of people aged 80 years or older is projected to triple between 2020 and 2050, reaching 426 million. This rising elderly population is expected to increase the volume of abdominal, gynecological, orthopedic, cardiovascular, and other surgical procedures, thereby driving the demand for adhesion barrier products to reduce the risk of post-surgical adhesions and related complications.
The reluctance of some surgeons to routinely use adhesion barrier products remains a key restraint for the adhesion barrier market. Despite their role in reducing post-surgical adhesions, adoption is often limited by concerns regarding product handling, placement difficulty, additional procedure time, and uncertainty around clinical outcomes across different surgical applications. In some cases, surgeons may also prefer conventional surgical techniques and meticulous tissue handling over the use of adjunctive barrier products. Limited awareness, lack of standardized usage protocols, and variability in surgeon experience further restrict the consistent use of adhesion barriers, particularly in cost-sensitive healthcare settings.
Adhesion barrier penetration remains low in the Asia-Pacific, Latin America, and the Middle East & Africa. In the coming years, countries such as South Korea, China, India, Mexico, and Brazil are expected to offer significant growth opportunities for players operating in the adhesion barriers market, as these countries have large patient bases for target indications, including cardiovascular, orthopedic, general/abdominal, and gynecological disorders. The number of surgical procedures, such as cardiac, general & abdominal, urological, gynecological, and orthopedic surgeries, is also on the rise in countries across emerging markets. Additionally, the number of surgeries being performed across APAC and the Middle East is increasing, owing to an influx of medical tourists in these regions. The rising disease burden and surgical volume in emerging markets are expected to create growth opportunities for key players operating in the adhesion barriers market.
Stringent regulatory requirements remain a major challenge for the adhesion barrier market, as the development of new products requires significant investment, extensive clinical validation, and long approval timelines, often extending beyond 7–8 years. The cost and time involved in moving a product from development to clinical trials and eventual marketing approval are considerably high, while the chances of approval remain uncertain. In addition, generating clinically significant safety and efficacy data for adhesion barriers is challenging, as outcomes can vary based on surgical technique, procedure type, patient condition, and product placement. As a result, despite high R&D investments, the risk of product failure remains substantial, discouraging companies from aggressively developing novel adhesion barrier technologies and limiting innovation in the market.
ADHESION BARRIER MARKET: COMMERCIAL USE CASES ACROSS INDUSTRIES
| COMPANY | USE CASE DESCRIPTION | BENEFITS |
|---|---|---|
|
|
Seprafilm Adhesion Barrier is a bioresorbable HA/CMC film used in abdominal and pelvic laparotomy procedures to reduce the incidence, extent, and severity of post-surgical adhesions between abdominal/pelvic tissues and organs. | Reduces adhesion-related post-operative complications; supports improved surgical outcomes in abdominopelvic procedures; offers a strong clinical legacy and broad hospital adoption. |
|
|
GYNECARE INTERCEED Absorbable Adhesion Barrier is an oxidized regenerated cellulose fabric used as an adjunct in open gynecologic pelvic surgery to reduce post-operative pelvic adhesions after meticulous hemostasis is achieved. | Helps reduce pelvic adhesion formation; supports fertility-preserving and gynecological surgical procedures; provides an absorbable, single-layer barrier between adjacent tissues. |
|
|
MediShield Anti-Adhesion Gel is a resorbable gel placed in the epidural space after spine surgery to create a temporary mechanical barrier between opposing tissue surfaces and reduce peridural adhesions. | Helps inhibit peridural adhesion formation; supports pain reduction and improved post-operative recovery in spine procedures; offers a biocompatible and easy-to-apply gel format. |
|
|
DuraGen Plus Adhesion Barrier Matrix is used in cranial and spinal procedures as a dural repair/restoration matrix and has been positioned for prophylactic adhesion prevention by protecting the nerve root from post-operative scar formation. | Supports dural repair while helping reduce scar-related adhesions; provides a collagen-based matrix for neurosurgical applications; improves protection of delicate neural structures after surgery. |
|
|
Hyalobarrier Gel/Gel Endo is a hyaluronic acid-based absorbable gel designed to prevent or reduce post-surgical adhesion formation in the abdomino-pelvic area, including open and laparoscopic procedures. | Reduces adhesion formation in gynecological and abdominal surgeries; enables targeted application through gel formulation; supports minimally invasive procedures and improved patient recovery. |
Logos and trademarks shown above are the property of their respective owners. Their use here is for informational and illustrative purposes only.
MARKET ECOSYSTEM
The adhesion barrier market ecosystem comprises key stakeholders, including manufacturers, distributors, healthcare providers, regulatory bodies, and end users, who collectively support product development, commercialization, clinical adoption, and compliance. Manufacturers such as Johnson & Johnson, Baxter, Integra LifeSciences, Terumo, FzioMed, and Anika Therapeutics develop film-, gel-, and liquid-based adhesion barrier products for use across gynecological, general/abdominal, orthopedic, cardiovascular, neurological, and other surgical procedures. Distributors and supply chain partners such as McKesson, Cardinal Health, Medline, and Owens & Minor ensure product availability across hospitals, ambulatory surgical centers, and specialty clinics. Healthcare providers and surgeons serve as key decision-makers, selecting products based on clinical evidence, ease of use, safety, cost, and procedural suitability, while regulatory bodies such as the US FDA, EMA, UK MHRA, and other national authorities oversee approvals, quality standards, and post-market compliance. Together, these stakeholders shape the dynamics of innovation, accessibility, and growth in the global adhesion barrier market.
Logos and trademarks shown above are the property of their respective owners. Their use here is for informational and illustrative purposes only.
MARKET SEGMENTS
Source: Secondary Research, Interviews with Experts, MarketsandMarkets Analysis
Synthetic adhesion barriers are among the most widely used products for post-surgical adhesion prevention, accounting for the largest share of the adhesion barriers market in 2025 and growing at the fastest CAGR. Their strong adoption is mainly attributed to their bioresorbable nature, which eliminates the need for a second surgery for implant removal. In addition, synthetic barriers are generally more cost-effective than natural adhesion barriers, making them suitable for broader use across hospitals and surgical centers. These products also offer advantages such as consistent quality, controlled degradation, ease of handling, and reduced risk of disease transmission compared to biologically derived materials. The growing preference for advanced polymer- and hyaluronic acid-based barriers across gynecological, abdominal, and orthopedic procedures is further supporting growth in this segment.
In 2025, film formulations dominated the market, owing to the availability of a wide range of film-based adhesion barrier products and strong clinical evidence supporting their safety and efficacy. Their ease of application, ability to provide a physical barrier between injured tissues, and suitability across multiple surgical procedures have increased their adoption among surgeons compared to gel- and liquid-based formulations. In addition, film formulations are widely used in gynecological, abdominal, and pelvic surgeries, where precise placement and the prevention of localized adhesion are critical. The established commercial presence of leading film-based products and continued surgeon familiarity with these barriers further support the growth of this segment.
Depending on the end user, the adhesion barriers market is segmented into hospitals & clinics, ambulatory surgical centers, and other end users. In 2025, hospitals & clinics dominated the market, owing to the large volume of surgical procedures performed in hospital settings. The availability of advanced surgical infrastructure, skilled surgeons, and specialized departments for gynecological, abdominal, orthopedic, cardiovascular, and neurological procedures further supports the higher adoption of adhesion barrier products in this segment. In addition, hospitals are often early adopters of advanced surgical products due to better purchasing capacity, established procurement channels, and greater focus on reducing post-surgical complications and readmissions. The growing number of inpatient and complex surgeries across developed and emerging economies is further expected to sustain the dominance of hospitals & clinics in the adhesion barriers market.
REGION
Asia Pacific to be fastest-growing region in global adhesive barrier monitor market during forecast period
The Asia Pacific region is projected to have the highest CAGR in the adhesive barrier market during the forecast period. It is the most lucrative healthcare market due to its large population and expanding healthcare sector. Factors such as rapid economic growth in China and Japan, the existence of a universal healthcare reimbursement policy, and large, growing populations in countries like China and India contribute to its rapid growth. Additionally, the increasing prevalence of diseases and government initiatives—such as establishing new healthcare systems for the aging population, increasing funding for healthcare infrastructure, and rising demand for surgical procedures—are fueling the need for improved healthcare facilities, medical devices, and technologies in the region.
ADHESION BARRIER MARKET: COMPANY EVALUATION MATRIX
In the adhesion barrier market matrix, Baxter (Star) holds a leading position due to its strong global presence, established relationships with hospitals, and well-recognized adhesion barrier portfolio led by Seprafilm. The company continues to maintain its leadership through broad clinical adoption, strong brand credibility, and integration within its advanced surgery business. FzioMed (Emerging Leader) is gaining traction with its specialized gel-based adhesion barrier products used across spine, orthopedic, tendon, peripheral nerve, and abdominal procedures. With its focused biomaterial platform and expanding international presence, FzioMed is well-positioned for upward movement in the matrix as demand for advanced, easy-to-apply adhesion prevention solutions increases.
Source: Secondary Research, Interviews with Experts, MarketsandMarkets Analysis
KEY MARKET PLAYERS
MARKET SCOPE
| REPORT METRIC | DETAILS |
|---|---|
| Market Size Value in 2025 (Value) | USD 0.73 Billion |
| Market Forecast in 2026 (Value) | USD 0.78 Billion |
| Market Forecast in 2031 (Value) | USD 1.11 Billion |
| Growth Rate | CAGR of 7.3% from 2026–2031 |
| Years Considered | 2024–2031 |
| Base Year | 2025 |
| Forecast Period | 2026-2031 |
| Units Considered | Value (USD BN), Volume (Thousands Units) |
| Report Coverage | Revenue Forecast, Company Ranking, Competitive Landscape, Growth Factors, and Trends |
| Segments Covered | By Product: Synthetic Products, Natural Products I By Formulation: Film Formulation, Gel Formulation, Liquid Formulation I By Application: Gynecological Surgeries, General/Abdominal Surgeries, Orthopedic Surgeries, Cardiovascular Surgeries, Neurological Surgeries, Urological Surgeries, Reconstructive Surgeries, Other Surgeries I By End User: Hospitals & Clinics, ASCs, Other End Users |
| Regions Covered | North America, Europe, Asia Pacific, Latin America, and the Middle East & Africa |
WHAT IS IN IT FOR YOU: ADHESION BARRIER MARKET REPORT CONTENT GUIDE
DELIVERED CUSTOMIZATIONS
We have successfully delivered the following deep-dive customizations:
| CLIENT REQUEST | CUSTOMIZATION DELIVERED | VALUE ADDS |
|---|---|---|
| Volume Analysis | Market assessment by volume (units) for adhesive barrier products used in hospitals & clinics |
|
| Company Information |
|
Insights on revenue shifts toward emerging innovations |
| Disease Prevalence |
RECENT DEVELOPMENTS
- November 2025 : Fziomed, Inc. (US) announced the initiation of commercialization of Oxiplex gel in the United States, indicated for reducing postoperative leg pain and neurological symptoms in adult patients undergoing lumbar spine procedures.
- October 2022 : WOMED (France) received ANVISA approval for the Womed Leaf Resorbable Adhesion Barrier, intended to prevent or reduce the formation of new or recurrent intrauterine adhesions by creating a temporary mechanical barrier.
Table of Contents
Exclusive indicates content/data unique to MarketsandMarkets and not available with any competitors.
4
MARKET OVERVIEW
Highlights the market structure, growth drivers, restraints, and near-term inflection points influencing performance.4.3
UNMET NEEDS AND WHITE SPACES
4.4
INTERCONNECTED MARKETS AND CROSS-SECTOR OPPORTUNITIES
4.5
STRATEGIC MOVES BY TIER-1/2/3 PLAYERS
5
INDUSTRY TRENDS
Captures industry movement, adoption patterns, and strategic signals across key end-use segments and regions.5.1
PORTER’S FIVE FORCES ANALYSIS
5.2
MACROECONOMIC OUTLOOK
5.2.2
GDP TRENDS AND FORECAST
5.2.3
TRENDS IN BIOSURGERY INDUSTRY
5.3
SUPPLY CHAIN ANALYSIS
5.6.1
AVERAGE SELLING PRICE TREND OF ADHESION BARRIERS, BY KEY PLAYER (2023-2025)
5.6.2
AVERAGE SELLING PRICE TREND, BY REGION (2023-2025)
5.7.1
IMPORT SCENARIO (HS CODE 300610)
5.7.2
EXPORT SCENARIO (HS CODE 300610)
5.8
KEY CONFERENCES AND EVENTS, 2026–2027
5.9
TRENDS/DISRUPTIONS IMPACTING CUSTOMERS’ BUSINESSES
5.10
INVESTMENT AND FUNDING SCENARIO
5.12
IMPACT OF 2025 US TARIFF – ADHESION BARRIER MARKET
5.12.3
PRICE IMPACT ANALYSIS
5.12.4
IMPACT ON COUNTRIES/REGIONS
5.12.5
IMPACT ON END-USE INDUSTRIES
6
TECHNOLOGICAL ADVANCEMENTS, AI-DRIVEN IMPACT, PATENTS, INNOVATIONS, AND FUTURE APPLICATIONS
6.1
KEY EMERGING TECHNOLOGIES
6.2
COMPLEMENTARY TECHNOLOGIES
6.3
ADJACENT TECHNOLOGIES
6.4
TECHNOLOGY/PRODUCT ROADMAP
6.6
IMPACT OF AI/GEN AI ON ADHESION BARRIER MARKET
6.6.1
TOP USE CASES AND MARKET POTENTIAL
6.6.2
CASE STUDIES OF AI IMPLEMENTATION IN THE ADHESION BARRIER MARKET
6.6.3
INTERCONNECTED ADJACENT ECOSYSTEM AND IMPACT ON MARKET PLAYERS
6.6.4
CLIENTS’ READINESS TO ADOPT GENERATIVE AI IN ADHESION BARRIER MARKET
7.1
REGIONAL REGULATIONS AND COMPLIANCE
7.1.1
REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
7.2
CERTIFICATIONS, LABELING, ECO-STANDARDS
8
CUSTOMER LANDSCAPE & BUYER BEHAVIOR
8.2
DECISION-MAKING PROCESS
8.3
KEY STAKEHOLDERS INVOLVED IN BUYING PROCESS AND THEIR EVALUATION CRITERIA
8.3.1
KEY STAKEHOLDERS IN BUYING PROCESS
8.4
ADOPTION BARRIERS & INTERNAL CHALLENGES
8.5
UNMET NEEDS FROM VARIOUS END-USE INDUSTRIES
9
ADHESION BARRIER MARKET, BY PRODUCT, 2024-2031 (USD MILLION)
9.2.2
REGENERATED CELLULOSE
9.2.3
POLYETHYLENE GLYCOL
9.2.4
OTHER SYNTHETIC ADHESION BARRERS
10
ADHESION BARRIER MARKET, BY FORMULATION, 2024-2031 (USD MILLION)
11
ADHESION BARRIER MARKET, BY APPLICATION, 2024-2031 (USD MILLION)
11.2
GYNECOLOGICAL SURGERIES
11.3
GENERAL/ABDOMINAL SURGERIES
11.4
ORTHOPEDIC SURGERIES
11.5
CARDIOVASCULAR SURGERIES
11.6
NEUROLOGICAL SURGERIES
11.7
UROLOGICAL SURGERIES
11.8
RECONSTRUCTIVE SURGERIES
12
ADHESION BARRIER MARKET, BY END USER, 2024-2031 (USD MILLION)
12.3
AMBULATORY SURGICAL CENTERS
13
ADHESION BARRIER MARKET, BY REGION, 2024-2031 (USD MILLION)
13.2.1
MACROECONOMIC OUTLOOK FOR EUROPE
13.3.1
MACROECONOMIC OUTLOOK FOR NORTH AMERICA
13.4.1
MACROECONOMIC OUTLOOK FOR ASIA PACIFIC
13.4.7
REST OF ASIA PACIFIC
13.5.1
MACROECONOMIC OUTLOOK FOR LATIN AMERICA
13.5.4
REST OF LATIN AMERICA
13.6
MIDDLE EAST & AFRICA
13.6.1
MACROECONOMIC OUTLOOK FOR MIDDLE EAST & AFRICA
13.6.3
REST OF MIDDLE EAST & AFRICA
14.2
KEY PLAYER STRATEGIES/RIGHT TO WIN (JANUARY 2022- JANUARY 2026)
14.3
REVENUE SHARE ANALYSIS OF TOP MARKET PLAYERS 2022-2025
14.4
MARKET SHARE ANALYSIS,
14.5
COMPANY EVALUATION MATRIX: KEY PLAYERS,
14.5.5
COMPANY FOOTPRINT: KEY PLAYERS,
14.5.5.1
COMPANY FOOTPRINT
14.5.5.2
REGION FOOTPRINT
14.5.5.3
PRODUCT FOOTPRINT
14.5.5.4
FORMULATION FOOTPRINT
14.5.5.5
APPLICATION FOOTPRINT
14.6
COMPANY EVALUATION MATRIX: STARTUPS/SMES,
14.6.1
PROGRESSIVE COMPANIES
14.6.2
RESPONSIVE COMPANIES
14.6.5
COMPETITIVE BENCHMARKING: STARTUPS/SMES,
14.6.5.1
DETAILED LIST OF KEY STARTUPS/SMES
14.6.5.2
COMPETITIVE BENCHMARKING OF STARTUPS/SMES
14.7
COMPETITIVE SCENARIO
14.7.1
PRODUCT APPROVALS & LAUNCHES
14.7.4
OTHER DEVELOPMENTS
14.8
R&D ASSESSMENT OF KEY PLAYERS
14.9
COMPANY VALUATION AND FINANCIAL METRICS
(BUSINESS OVERVIEW, FINANCIALS, RECENT DEVELOPMENTS, MNM VIEW)
15.1.4
INTEGRA LIFESCIENCES CORPORATION
15.1.5
ANIKA THERAPEUTICS INC.
15.1.6
TERUMO CORPORATION
15.1.12
WL GORE & ASSOCIATES
15.1.14
HANGZHOU SINGCLEAN MEDICAL PRODUCTS CO., LTD.
15.1.15
BIOREGEN BIOMEDICAL (CHANGZHOU) CO., LTD.
15.2.2
PLANTTEC MEDICAL GMBH
15.2.4
SAMYANG BIOPHARM CORPORATION
15.2.6
PROVIEW-MBD BIOTECH CO., LTD.
15.2.8
ALAFAIR BIOSCIENCES
15.2.9
SCIVISION BIOTECH INC.
16.1.1.1
KEY DATA FROM SECONDARY SOURCES
16.1.2.1
KEY DATA FROM PRIMARY SOURCES
16.1.2.2
KEY PRIMARY PARTICIPANTS
16.1.2.3
BREAKDOWN OF PRIMARY INTERVIEWS
16.1.2.4
KEY INDUSTRY INSIGHTS
16.2
MARKET SIZE ESTIMATION
16.2.1
BOTTOM-UP APPROACH
16.3
MARKET FORECAST APPROACH
16.6
RESEARCH ASSUMPTIONS AND LIMITATIONS
17.1
INSIGHTS OF INDUSTRY EXPERTS
17.3
KNOWLEDGE STORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL
17.4
CUSTOMIZATION OPTIONS
Methodology
The study involved four major activities in estimating the current size of the adhesion barrier market. Exhaustive secondary research was conducted to gather information on the market, the peer market, and the parent market. The next step was to validate these findings, assumptions, and sizing with industry experts across the value chain through primary research. Both top-down and bottom-up approaches were employed to estimate the complete market size. After that, market breakdown and data triangulation were used to estimate the market size of segments and subsegments.
Secondary Research
Secondary sources used in this research study include financial statements of companies offering adhesion barriers and information from various trade, business, and professional associations. The secondary data were collected and analyzed to determine the overall size of the adhesion barrier market, a finding that primary respondents validated.
Primary Research
Extensive primary research was conducted after obtaining information regarding the adhesion barrier market scenario through secondary research. Several primary interviews were conducted with market experts from both the demand and supply sides across major countries of North America, Europe, Asia Pacific, Latin America, and the Middle East & Africa. Primary data was collected through questionnaires, emails, and telephonic interviews. The primary sources from the supply side included industry experts, such as Chief X Officers (CXOs), Vice Presidents (VPs), and Directors from business development, marketing, and product development/innovation teams, as well as key executives from adhesion barrier manufacturers, distributors, and key opinion leaders.
Primary interviews were conducted to gather insights, including market statistics, revenue data from products and services, market breakdowns, market size estimates, market forecasts, and triangulation. Primary research also helped in understanding the various trends related to technology, applications, verticals, and regions. Stakeholders from the demand side, customer/end users who are using adhesion barrier, were interviewed to understand the buyer’s perspective on the suppliers, products, and their current usage of adhesion barrier and future outlook of their business, which will affect the overall market.
Note 1: C-level primaries include CEOs, COOs, CTOs, and VPs.
Note 2: Other primaries include sales managers, marketing managers, and product managers.
Note 3: Companies are classified into tiers based on their total revenue. As of 2025: Tier 1=>USD 1billion, Tier 2=USD 500 million to USD 1 billion, Tier 3=<USD 500 million.
To know about the assumptions considered for the study, download the pdf brochure
Market Size Estimation
The research methodology used to estimate the size of the adhesion barrier market is as follows.
Market sizing was conducted from a global perspective.
Country-level analysis: The size of the adhesion barrier market was obtained from annual presentations by leading players and from publicly available secondary data. The share of products and services in the overall adhesion barrier market was obtained from secondary data and validated with primary participants to arrive at the total market size. Primary participants further validated the numbers.
Geographic market assessment (by region & country): The geographic assessment was done using the following approaches:
Approach 1: Geographic revenue contributions/splits of leading players in the market (wherever available) and respective growth trends
Approach 2: Geographic adoption trends for individual product segments by end users and growth prospects for each of the segments (assumptions and indicative estimates validated from primary interviews)
At each point, the assumptions and approaches were validated through industry experts contacted during primary research. Considering the limitations of data available from secondary research, revenue estimates for individual companies (for the overall adhesion barrier market and geographic market assessment) were ascertained based on a detailed analysis of their respective product offerings, geographic reach/strength (direct or through distributors or suppliers), and the shares of the leading players in a particular region or country.
Data Triangulation
After arriving at the overall size from the market size estimation process explained above, the total market was split into several segments and subsegments. The data triangulation and market breakdown procedures explained below were implemented, where applicable, to complete the overall market engineering process and derive accurate statistics for various market segments and subsegments. The data was triangulated by studying various factors and trends from the demand and supply sides. Additionally, the market size was validated using both top-down and bottom-up approaches.
Market Definition
An adhesion barrier is a medical device implant used to prevent the formation of internal scarring between organs and internal tissues during the post-surgery period. They are available in gels, physical films, meshes, fabrics, and other forms. An adhesion barrier plays a critical role to prevent a patient from post-surgical complications.
Key Stakeholders
- Senior Management
- Finance Department
- Procurement Department
- Hospitals
- Specialty Clinics
- Trade Associations and Industry Bodies
- Regulatory Bodies and Government Agencies
- Business Research and Consulting Service Providers
- Market Research and Consulting Firms
- Venture Capitalists and Investors
Report Objectives
- To define, describe, segment, analyze, and forecast the global adhesion barrier market based on product, formulation, application, end user, and region.
- To provide detailed information regarding the major factors influencing the market growth (drivers, restraints, opportunities, and challenges)
- To analyze micromarkets with respect to individual growth trends, future prospects, and contributions to the overall market
- To analyze the opportunities in the market for stakeholders and provide details of the competitive landscape for market leaders
- To forecast the size of the adhesion barrier market with respect to five main regions (along with countries), namely, North America, Europe, the Asia Pacific, Latin America, and the Middle East & Africa
- To profile the key players in the global adhesion barrier market and comprehensively analyze their core competencies and market shares
- To track and analyze competitive developments such as acquisitions, product launches, regulatory approvals, and R&D activities of the leading players in the global adhesion barrier market
Available customizations:
With the given market data, MarketsandMarkets offers customizations as per the company’s specific needs. The following customization options are available for the report:
Geographic Analysis
- Further breakdown of the Rest of Europe adhesion barrier market into the Netherlands, Austria, Belgium, and others
- Further breakdown of the Rest of Asia Pacific adhesion barrier market into Singapore, Malaysia, and others
Company Information
- Detailed analysis and profiling of additional market players
Personalize This Research
- Triangulate with your Own Data
- Get Data as per your Format and Definition
- Gain a Deeper Dive on a Specific Application, Geography, Customer or Competitor
- Any level of Personalization
Let Us Help You
- What are the Known and Unknown Adjacencies Impacting the Adhesion Barrier Market
- What will your New Revenue Sources be?
- Who will be your Top Customer; what will make them switch?
- Defend your Market Share or Win Competitors
- Get a Scorecard for Target Partners
JAYANT RAJPUROHIT
Director of Market Insights, Data and Analytics
SFI Health,
Leading Pharmaceutical Company
We at SFI Health approached MarketsandMarkets for an Opportunity Assessment on "Incidence and Prevalence of Focus Indications" as we wanted to know the most attractive HCPs like Physician, Functional MD, Naturopath and Pharmacist. The project was critical for us to ensure our focus on the right target which would enable sustainable growth and profitability for SFI Health. The business insights provided exceeded our expectations and we were extremely impressed. The team at MarketsandMarkets is highly professional and detail oriented and very well understood our business needs. MarketsandMarkets offers a unique combination of expertise and dedicated engagement model. We identified 2 new products to be launched in coming months, based on the research findings provided by MarketsandMarkets. We are happy with the services and would strongly recommend MarketsandMarkets to my peers in the industry.
BEATRIZ DE LA CALLE
Head of Commercial Analytics
Qualicaps,
Leading Pharmaceutical Company
We partnered with MarketsandMarkets for an assessment study on hard empty capsules. The team was extremely professional in understanding our business requirements and we received timely responses to all our queries. The market intelligence and the recommendations has met our business requirements. We were extremely impressed to see the final study results; it really exceeded our expectations. The market intelligence offered by MarketsandMarkets, and clarity on next steps will help us achieve our business objective for the Year 2021. We are happy with the services and would strongly recommend MarketsandMarkets to my peers in the industry.
Bob Williams,
Senior Director Business Development & Innovation
Bracco Diagnostics Inc.,
Italian Multinational in life sciences sector and a World Leader in imaging diagnostics
We were pleased with targeted insights that MarketsandMarkets identified from a custom study on the 'Radiation Dose Management Solutions Market'. Your team identified and characterized the market participants as well as underlying trends accurately. This study was useful to Bracco in formulating business strategies for our dose monitoring product lines and we thank MarketsandMarkets for the job well done.
Cody Coonradt,
Market Development and Strategy Manager
3M Health Information Systems,
Leader in Health care Coding, Payment & Analytics Solutions.
The value for our organization comes from three things: depth of research, specificity of segments and being easy to work with. As important as the first two are, the third can't be underestimated. MarketsandMarkets, maybe more than any other research vendor, wants to know what is top of mind for our team and what big questions we are grappling to answer.
Their customer first approach and high value engagement model, have given us great analysis and excellent value for money
Схожие новости
Классификация: Пресс-релизы. Схожих патентов: 0. Схожих новостей: 10. Тональность: 0. Информативность: 5. Источник: www.marketsandmarkets.com.